APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 148 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 3.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,242,179 | -79.1% | 32,673 | -50.0% | 0.00% | -80.0% |
| Q2 2023 | $5,952,039 | +76.3% | 65,335 | +27.6% | 0.01% | +66.7% |
| Q1 2023 | $3,376,743 | +504.8% | 51,195 | +374.2% | 0.01% | +500.0% |
| Q4 2022 | $558,300 | -85.4% | 10,796 | -80.7% | 0.00% | -88.9% |
| Q3 2022 | $3,820,000 | +207.3% | 55,921 | +184.2% | 0.01% | +200.0% |
| Q2 2021 | $1,243,000 | +33.5% | 19,674 | +20.9% | 0.00% | +50.0% |
| Q1 2021 | $931,000 | 0.0% | 16,268 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $931,000 | +345.5% | 16,268 | +109.0% | 0.00% | +100.0% |
| Q1 2020 | $209,000 | – | 7,785 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
| ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
| Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
| Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
| Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
| EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
| Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
| Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
| Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
| Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |